130 related articles for article (PubMed ID: 9292925)
1. Characterization of a superantigen produced by Yersinia pseudotuberculosis.
Abe J; Takeda T
Prep Biochem Biotechnol; 1997; 27(2-3):173-208. PubMed ID: 9292925
[No Abstract] [Full Text] [Related]
2. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
[No Abstract] [Full Text] [Related]
3. Increased virulence of Yersinia pseudotuberculosis by two independent mutations.
Rosqvist R; Skurnik M; Wolf-Watz H
Nature; 1988 Aug; 334(6182):522-4. PubMed ID: 3043229
[TBL] [Abstract][Full Text] [Related]
4. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
[TBL] [Abstract][Full Text] [Related]
5. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains.
Yoshino K; Ramamurthy T; Nair GB; Fukushima H; Ohtomo Y; Takeda N; Kaneko S; Takeda T
J Clin Microbiol; 1995 Dec; 33(12):3356-8. PubMed ID: 8586739
[TBL] [Abstract][Full Text] [Related]
6. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
[TBL] [Abstract][Full Text] [Related]
7. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
[TBL] [Abstract][Full Text] [Related]
8. Sequencing of virulence genes shows limited genetic variability in Yersinia pseudotuberculosis.
Palonen E; Kangas S; Somervuo P; Lindström M; Fredriksson-Ahomaa M; Skurnik M; Korkeala H
Foodborne Pathog Dis; 2013 Jan; 10(1):21-7. PubMed ID: 23153288
[TBL] [Abstract][Full Text] [Related]
9. [Yersinia pseudotuberculosis toxins].
Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):83-9. PubMed ID: 17163146
[TBL] [Abstract][Full Text] [Related]
10. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
[TBL] [Abstract][Full Text] [Related]
11. Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
Carnoy C; Mullet C; Müller-Alouf H; Leteurtre E; Simonet M
Infect Immun; 2000 May; 68(5):2553-9. PubMed ID: 10768943
[TBL] [Abstract][Full Text] [Related]
12. The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.
Carnoy C; Floquet S; Marceau M; Sebbane F; Haentjens-Herwegh S; Devalckenaere A; Simonet M
J Bacteriol; 2002 Aug; 184(16):4489-99. PubMed ID: 12142419
[TBL] [Abstract][Full Text] [Related]
13. Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains.
Fukushima H; Matsuda Y; Seki R; Tsubokura M; Takeda N; Shubin FN; Paik IK; Zheng XB
J Clin Microbiol; 2001 Oct; 39(10):3541-7. PubMed ID: 11574570
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the role of invasin during Yersinia pseudotuberculosis infection of mice.
Marra A; Isberg RR
Ann N Y Acad Sci; 1996 Oct; 797():290-2. PubMed ID: 8993384
[No Abstract] [Full Text] [Related]
15. [Yersinia pseudotuberculosis infection].
Takeda N
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):496-9. PubMed ID: 10088455
[No Abstract] [Full Text] [Related]
16. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
[TBL] [Abstract][Full Text] [Related]
17. [Virulence of Yersinia pseudotuberculosis strains isolated from environment as a threat to human epidemic].
Czyzewska I; Furowicz AJ
Przegl Epidemiol; 2003; 57(2):263-70. PubMed ID: 12910593
[TBL] [Abstract][Full Text] [Related]
18. The superantigenic toxin of Yersinia pseudotuberculosis: a novel virulence factor?
Carnoy C; Müller-Alouf H; Desreumaux P; Mullet C; Grangette C; Simonet M
Int J Med Microbiol; 2000 Oct; 290(4-5):477-82. PubMed ID: 11111929
[TBL] [Abstract][Full Text] [Related]
19. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
20. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
